Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D.

Weinberg A, Huo Y, Kacanek D, Patel K, Watts DH, Wara D, Hoffman RM, Klawitter J, Christians U; for IMPAACT P1025 Team.

J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):181-187. doi: 10.1097/QAI.0000000000002111.

PMID:
31513074
2.

Ophthalmic manifestations of perinatally acquired HIV in a US cohort of long-term survivors.

Rutar T, Youm J, Porco T, Tilton N, Muskat M, McNamara N, Wara D.

Br J Ophthalmol. 2015 May;99(5):650-3. doi: 10.1136/bjophthalmol-2014-305557. Epub 2014 Nov 21.

PMID:
25416182
3.

Family adversity and autonomic reactivity association with immune changes in HIV-affected school children.

Thomas MR, Wara D, Saxton K, Truskier M, Chesney MA, Boyce WT.

Psychosom Med. 2013 Jul-Aug;75(6):557-65. doi: 10.1097/PSY.0b013e31829807fb. Epub 2013 Jun 13.

4.

The effect of prophylaxis on pediatric HIV costs.

Wilson LS, Hensic L, Paoli CJ, Basu R, Christenson M, Moskowitz JT, Wara D.

AIDS Care. 2012;24(1):108-18. doi: 10.1080/09540121.2011.592818. Epub 2011 Jul 25.

5.

Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.

Ma CA, Wang HY, Temmerman S, Zhao Y, Wu L, Hornung RL, Wara D, Jain A.

Hum Mutat. 2011 Mar;32(3):318-24. doi: 10.1002/humu.21439.

6.

Pediatric HIV costs across three treatment eras from 1986 to 2007.

Wilson LS, Basu R, Christenson M, Hensic L, Paoli C, Wara D, Moskowitz JT.

Pediatrics. 2010 Sep;126(3):e541-9. doi: 10.1542/peds.2009-3485. Epub 2010 Aug 9.

PMID:
20696721
7.

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.

Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M; IMPAACT P1057 Team.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):189-96. doi: 10.1097/QAI.0b013e3181e46308.

8.

Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome.

Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, Heyman MB, McCune JM, Wara DW.

Clin Immunol. 2009 Jul;132(1):124-31. doi: 10.1016/j.clim.2009.03.514. Epub 2009 Apr 16.

9.

Altered iron metabolism in children with human immunodeficiency virus disease.

Butensky James E, Harmatz P, Lee M, Kennedy C, Petru A, Wara D, Miaskowski C.

Pediatr Hematol Oncol. 2009 Mar;26(2):69-84. doi: 10.1080/08880010902754826.

PMID:
19322737
10.

Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Milojevic D, Nguyen KD, Wara D, Mellins ED.

Pediatr Rheumatol Online J. 2008 Dec 1;6:20. doi: 10.1186/1546-0096-6-20.

11.

Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.

Tremoulet AH, Capparelli EV, Patel P, Acosta EP, Luzuriaga K, Bryson Y, Wara D, Zorrilla C, Holland D, Mirochnick M; Pediatric AIDS Clinical Trials Group.

Antimicrob Agents Chemother. 2007 Dec;51(12):4297-302. Epub 2007 Sep 24.

12.

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

Pahwa S, Muresan P, Sleasman J, Fenton T, Moye J, Deveikis A, Wara D, Van Dyke R; Pediatric Aids Clinical Trials Study 402 team.

J Allergy Clin Immunol. 2007 Jun;119(6):1538-41. Epub 2007 Apr 5. No abstract available.

PMID:
17418382
13.

JC virus granule cell neuronopathy in a child with CD40 ligand deficiency.

Hecht JH, Glenn OA, Wara DW, Wu YW.

Pediatr Neurol. 2007 Mar;36(3):186-9.

PMID:
17352955
14.

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Unadkat JD, Wara DW, Hughes MD, Mathias AA, Holland DT, Paul ME, Connor J, Huang S, Nguyen BY, Watts DH, Mofenson LM, Smith E, Deutsch P, Kaiser KA, Tuomala RE.

Antimicrob Agents Chemother. 2007 Feb;51(2):783-6. Epub 2006 Dec 11.

15.

Index of suspicion.

Taylor Z, Butani L, Blumberg D, Cowan M, Wara D, Gopal S, Gavrilita C, Da-Silva S.

Pediatr Rev. 2006 Dec;27(12):463-9. No abstract available.

PMID:
17142468
16.

Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils.

Zhang H, Schaff UY, Green CE, Chen H, Sarantos MR, Hu Y, Wara D, Simon SI, Lowell CA.

Immunity. 2006 Aug;25(2):285-95. Epub 2006 Aug 10.

17.

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.

Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W; Pediatric AIDS Clinical Trials Group 1008 Team.

J Infect Dis. 2006 Jan 15;193(2):302-11. Epub 2005 Dec 7.

PMID:
16362896
18.

Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).

Chan B, Wara D, Bastian J, Hershfield MS, Bohnsack J, Azen CG, Parkman R, Weinberg K, Kohn DB.

Clin Immunol. 2005 Nov;117(2):133-43. Epub 2005 Aug 22.

PMID:
16112907
19.

Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen.

Cohan D, Feakins C, Wara D, Petru A, McNicholl I, Schillinger D, Lu J, Kuritzkes D, Deeks SG.

AIDS. 2005 Jun 10;19(9):989-90. No abstract available.

PMID:
15905684
20.

Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability.

von Scheven E, Lu TT, Emery HM, Elder ME, Wara DW.

Arthritis Rheum. 2003 Dec 15;49(6):862-5. No abstract available.

21.

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA; Pediatric AIDS Clinical Trials Group.

J Allergy Clin Immunol. 2003 Nov;112(5):973-80.

PMID:
14610491
22.

When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected children.

Lester P, Chesney M, Cooke M, Weiss R, Whalley P, Perez B, Glidden D, Petru A, Dorenbaum A, Wara D.

J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):309-17.

PMID:
12439206
23.

Increasing women's leadership in academic medicine: report of the AAMC Project Implementation Committee.

Bickel J, Wara D, Atkinson BF, Cohen LS, Dunn M, Hostler S, Johnson TR, Morahan P, Rubenstein AH, Sheldon GF, Stokes E; Association of American Medical Colleges Project Implementation Committee.

Acad Med. 2002 Oct;77(10):1043-61.

PMID:
12377686
24.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

25.

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.

McFarland EJ, Borkowsky W, Fenton T, Wara D, McNamara J, Samson P, Kang M, Mofenson L, Cunningham C, Duliege AM, Sinangil F, Spector SA, Jimenez E, Bryson Y, Burchett S, Frenkel LM, Yogev R, Gigliotti F, Luzuriaga K, Livingston RA; AIDS Clinical Trials Group 230 Collaborators.

J Infect Dis. 2001 Nov 15;184(10):1331-5. Epub 2001 Oct 10.

PMID:
11679925
26.

Oral manifestations and dental status in paediatric HIV infection.

Ramos-Gomez FJ, Petru A, Hilton JF, Canchola AJ, Wara D, Greenspan JS.

Int J Paediatr Dent. 2000 Mar;10(1):3-11.

PMID:
11310124
27.

Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.

Cunningham CK, Wara DW, Kang M, Fenton T, Hawkins E, McNamara J, Mofenson L, Duliege AM, Francis D, McFarland EJ, Borkowsky W; Pediatric AIDS Clinical Trials Group 230 Collaborators.

Clin Infect Dis. 2001 Mar 1;32(5):801-7. Epub 2001 Feb 28.

PMID:
11229849
28.

Ensuring the success of women faculty at AMCs: lessons learned from the National Centers of Excellence in Women's Health.

Morahan PS, Voytko ML, Abbuhl S, Means LJ, Wara DW, Thorson J, Cotsonas CE.

Acad Med. 2001 Jan;76(1):19-31.

PMID:
11154189
29.

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, Shapira SK, Farndon PA, Wara DW, Emmal SA, Ferguson BM.

Am J Hum Genet. 2000 Dec;67(6):1555-62. Epub 2000 Oct 24.

30.

Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team.

Shearer WT, Israel RJ, Starr S, Fletcher CV, Wara D, Rathore M, Church J, DeVille J, Fenton T, Graham B, Samson P, Staprans S, McNamara J, Moye J, Maddon PJ, Olson WC.

J Infect Dis. 2000 Dec;182(6):1774-9. Epub 2000 Oct 27.

PMID:
11069253
31.

Shipment impairs lymphocyte proliferative responses to microbial antigens.

Betensky RA, Connick E, Devers J, Landay AL, Nokta M, Plaeger S, Rosenblatt H, Schmitz JL, Valentine F, Wara D, Weinberg A, Lederman HM.

Clin Diagn Lab Immunol. 2000 Sep;7(5):759-63.

32.

Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns.

Kliks S, Contag CH, Corliss H, Learn G, Rodrigo A, Wara D, Mullins JI, Levy JA.

AIDS Res Hum Retroviruses. 2000 Sep 1;16(13):1223-33.

PMID:
10957720
33.

Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.

Fahey JL, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey JL, Seigel J, Landay AL, Kilarui R, Schmitz JL, White C, Wara DW, Akridge R, Cutili J, Douglas SD, Reuben J, Shearer WT, Nokta M, Polland R, Schooley R, Asthana D, Mizrachi Y, Waxdal M.

Clin Diagn Lab Immunol. 2000 Jul;7(4):540-8.

34.

Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators.

Borkowsky W, Wara D, Fenton T, McNamara J, Kang M, Mofenson L, McFarland E, Cunningham C, Duliege AM, Francis D, Bryson Y, Burchett S, Spector SA, Frenkel LM, Starr S, Van Dyke R, Jimenez E.

J Infect Dis. 2000 Mar;181(3):890-6.

PMID:
10720509
35.

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).

Stiehm ER, Fletcher CV, Mofenson LM, Palumbo PE, Kang M, Fenton T, Sapan CV, Meyer WA, Shearer WT, Hawkins E, Fowler MG, Bouquin P, Purdue L, Sloand EM, Nemo GJ, Wara D, Bryson YJ, Starr SE, Petru A, Burchett S.

J Infect Dis. 2000 Feb;181(2):548-54.

PMID:
10669338
36.

Cytokine profile of a long-term pediatric HIV survivor with hyper-IgE syndrome and a normal CD4 T-cell count.

Seroogy CM, Wara DW, Bluth MH, Dorenbaum A, White C, Durkin HG, Elder ME.

J Allergy Clin Immunol. 1999 Nov;104(5):1045-51.

PMID:
10550751
37.

Sleep disturbances in children with human immunodeficiency virus infection.

Franck LS, Johnson LM, Lee K, Hepner C, Lambert L, Passeri M, Manio E, Dorenbaum A, Wara D.

Pediatrics. 1999 Nov;104(5):e62.

PMID:
10545588
38.

Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.

Mirochnick M, Cooper E, McIntosh K, Xu J, Lindsey J, Jacobus D, Mofenson L, Sullivan JL, Dankner W, Frenkel LM, Nachman S, Wara DW, Johnson D, Bonagura VR, Rathore MH, Cunningham CK, McNamara J.

Antimicrob Agents Chemother. 1999 Nov;43(11):2586-91.

39.

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.

Wright PF, Lambert JS, Gorse GJ, Hsieh RH, McElrath MJ, Weinhold K, Wara DW, Anderson EL, Keefer MC, Jackson S, Wagner LJ, Francis DP, Fast PE, McNamara J.

J Infect Dis. 1999 Oct;180(4):1080-8.

PMID:
10479134
40.

Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.

Dunbar C, Chang L, Mullen C, Ramsey WJ, Carter C, Kohn D, Parkman R, Lenarsky C, Weinberg K, Wara D, Culver KW, Anderson WF, Leitman S, Fleisher T, Klein H, Shearer G, Clerici M, McGarrity G, Bastian J, Hershfield MS.

Hum Gene Ther. 1999 Feb 10;10(3):477-88. No abstract available.

PMID:
10048399
41.

Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999.

Wilfert C, Aronson JE, Beck DT, Fleischman AR, Kline MW, Mofenson LM, Scott GB, Wara DW, Whitley-Williams PN.

Pediatrics. 1999 Feb;103(2):509-11.

PMID:
9925854
42.

Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218).

Lambert JS, McNamara J, Katz SL, Fenton T, Kang M, VanCott TC, Livingston R, Hawkins E, Moye J Jr, Borkowsky W, Johnson D, Yogev R, Duliege AM, Francis D, Gershon A, Wara D, Martin N, Levin M, McSherry G, Smith G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):451-61.

PMID:
9859958
43.

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.

McKinney RE Jr, Johnson GM, Stanley K, Yong FH, Keller A, O'Donnell KJ, Brouwers P, Mitchell WG, Yogev R, Wara DW, Wiznia A, Mofenson L, McNamara J, Spector SA.

J Pediatr. 1998 Oct;133(4):500-8.

PMID:
9787687
44.

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotto F, Annett G, Nolta JA, Crooks G, Kapoor N, Elder M, Wara D, Bowen T, Madsen E, Snyder FF, Bastian J, Muul L, Blaese RM, Weinberg K, Parkman R.

Nat Med. 1998 Jul;4(7):775-80.

45.

CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children.

Levy JA, Hsueh F, Blackbourn DJ, Wara D, Weintrub PS.

J Infect Dis. 1998 Feb;177(2):470-2.

PMID:
9466540
46.

Funding for patient-oriented research. Critical strain on a fundamental linchpin.

Williams GH, Wara DW, Carbone P.

JAMA. 1997 Jul 16;278(3):227-31.

PMID:
9218670
48.

Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group.

Spector SA, Blanchard S, Wara DW, Oleske JM, McIntosh K, Hodes D, Dankner WM, Salgo M, McNamara J.

Pediatr Infect Dis J. 1997 Jun;16(6):623-6. No abstract available.

PMID:
9194115
49.

Transmission of HIV-1 in infants born to seropositive mothers: PCR-amplified proviral DNA detected by flow cytometric analysis of immunoreactive beads.

Dorenbaum A, Venkateswaran KS, Yang G, Comeau AM, Wara D, Vyas GN.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1;15(1):35-42.

PMID:
9215652
50.

A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors.

Nielsen K, McSherry G, Petru A, Frederick T, Wara D, Bryson Y, Martin N, Hutto C, Ammann AJ, Grubman S, Oleske J, Scott GB.

Pediatrics. 1997 Apr;99(4):E4.

PMID:
9099779

Supplemental Content

Support Center